Skip to main content
Log in

Small renal size in newborns with spina bifida: possible causes

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Previous studies reported that children with neural tube defects, but without any history of intrinsic renal diseases, have small kidneys when compared with age-matched standard renal growth. The aim of this study was to investigate the possible causes of small renal size in children with spina bifida by comparing growth hormone deficiency, physical limitations and hyperhomocysteinemia.

Methods

The sample included 187 newborns with spina bifida. Renal sizes in the patients were assessed by using maximum measurement of renal length and the measurements were compared by using the Sutherland monogram. According to the results, the sample was divided into two groups—a group of 120 patients with small kidneys (under the third percentile) and a control group of 67 newborns with normal kidney size. Plasma total homocysteine was investigated in mothers and in their children. Serum insulin-like growth factor-1 (IGF-1) levels were measured.

Results

Serum IGF-1 levels were normal in both groups. Children and mothers with homocysteine levels >10 μmol/l were more than twice as likely to have small kidneys and to give to birth children with small kidneys, respectively, compared with newborns and mothers with homocysteine levels <10 μmol/l. An inverse correlation was also found between the homocysteine levels of mothers and kidney sizes of children (r = − 0.6109 P ≤ 0.01).

Conclusions

It is highly important for mothers with hyperhomocysteinemia to be educated about benefits of folate supplementation in order to reduce the risk of small renal size and lower renal function in children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sutherland RW, Wiener JS, Roth DR, Gonzales ET Jr. A renal size nomogram for the patient with myelomeningocele. J Urol. 1997;158:1265–7.

    Article  CAS  PubMed  Google Scholar 

  2. Gross GW, Thornburg AJ, Bellinger MF. Normal renal growth in children with myelodysplasia. Am J Roentgenol. 1986;146:615–7.

    Article  CAS  Google Scholar 

  3. Del Gado R, Perrone L, Del Gaizo D, et al. Renal size and function in patients with neuropathic bladder due to myelomeningocele: the role of growth hormone. J Urol. 2003;170:1960–1.

    Article  PubMed  Google Scholar 

  4. Rotenstein D, Breen TJ. Growth hormone treatment of children with myelomeningocele. J Pediatr. 1996;128:S28–31.

    Article  CAS  PubMed  Google Scholar 

  5. Herrmann W. The importance of hyperhomocysteinemia as a risk factor for diseases: an overview. Clin Chem Lab Med. 2001;39:666–74.

    CAS  PubMed  Google Scholar 

  6. Carlo WA. The fetus and the neonatal infant. In: Kliegman RM, Stanton B, St. Geme J, Schor N, Behrman RE, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia: Saunders; 2011. p. 532.

  7. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422:43–52.

    Article  CAS  PubMed  Google Scholar 

  8. Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20:629–37.

    Article  PubMed  Google Scholar 

  9. Filler G, Gharib M, Casier S, Lödige P, Ehrich JH, Dave S. Prevention of chronic kidney disease in spina bifida. Int Urol Nephrol. 2011;44:817–27.

    Article  PubMed  Google Scholar 

  10. Felkner M, Suarez L, Canfield MA, Brender JD, Sun Q. Maternal serum homocysteine and risk for neural tube defects in a Texas-Mexico border population. Birth Defects Res A Clin Mol Teratol. 2009;85:574–81.

    Article  CAS  PubMed  Google Scholar 

  11. van der Put NM, Thomas CM, Eskes TK, Trijbels FJ, Steegers-Theunissen RP, Mariman EC, et al. Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM. 1997;90:505–10.

    Article  PubMed  Google Scholar 

  12. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr. 2000;71:62–8.

    Google Scholar 

  13. Khong T, Hague W. The placenta in maternal hyperhomocysteinaemia. Br J Obstet Gynaecol. 1999;106:273–8.

    Article  CAS  PubMed  Google Scholar 

  14. Wilson RD, Johnson JA, Wyatt P, Allen V, Gagnon A, Langlois S, et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can. 2007;29:1003–26.

    PubMed  Google Scholar 

  15. Blencowe H, Cousens S, Modell B, Lawn J. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol. 2010;39:110–21.

    Article  Google Scholar 

  16. Wiltshire EJ, Couper JJ. Improved folate status in children and adolescents during voluntary fortification of food with folate. J Paediatr Child Health. 2004;40:44–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have declared that no conflict of interest exists.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luisa Montaldo.

About this article

Cite this article

Montaldo, P., Montaldo, L., Iossa, A.C. et al. Small renal size in newborns with spina bifida: possible causes. Clin Exp Nephrol 18, 120–123 (2014). https://doi.org/10.1007/s10157-013-0802-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-013-0802-z

Keywords

Navigation